PL120131, a peptide designed to mimic the PD-1-binding pocket in PD-L1, has been shown to interfere with the PD-1-PD-L1 interaction and promote the anti-tumor activity of cytotoxic T cells [13]. Here, PDCD1 is linked to neoplasm.